These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15151477)
41. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials? Ray KK; Cannon CP; Ganz P Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675 [TBL] [Abstract][Full Text] [Related]
43. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial). Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227 [TBL] [Abstract][Full Text] [Related]
44. [Favorable effects of decreasing lipids in patients with diabetes mellitus]. Gouni-Berthold I; Krone W Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581 [TBL] [Abstract][Full Text] [Related]
45. Cholesterol, lipids, and statins. Ballantyne CM Tex Heart Inst J; 2005; 32(3):378-9. PubMed ID: 16392223 [TBL] [Abstract][Full Text] [Related]
46. [Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study]. BĂ„venholm P; Attvall S; Nilsson PM Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2462-6. PubMed ID: 17002161 [No Abstract] [Full Text] [Related]
47. [Differentiated treatment of diabetics with an acute coronary syndrome]. Hamm CW; Hamann A Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250 [No Abstract] [Full Text] [Related]
48. Modifying plasma low-density lipoprotein and high-density lipoprotein cholesterol: what combinations are available in the future? Kastelein JJ Am J Cardiol; 2005 Nov; 96(9A):20K-27K; discussion 34K-35K. PubMed ID: 16291010 [TBL] [Abstract][Full Text] [Related]
50. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy. Wiviott SD; Cannon CP Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906 [TBL] [Abstract][Full Text] [Related]
51. [What other effects do statins have except their effect on lipids?]. Tikkanen MJ Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256 [No Abstract] [Full Text] [Related]
52. Triglyceride-rich lipoprotein remnant levels and metabolism: time to adopt these orphan risk factors? Brinton EA; Nanjee MN; Hopkins PN J Am Coll Cardiol; 2004 Jun; 43(12):2233-5. PubMed ID: 15193685 [No Abstract] [Full Text] [Related]
53. [Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high]. Einecke D MMW Fortschr Med; 2004 Mar; 146(13):4-5. PubMed ID: 15219114 [No Abstract] [Full Text] [Related]
54. Achieving lipid goals in Europe: how large is the treatment gap? Schwandt P; Brady AJ Expert Rev Cardiovasc Ther; 2004 May; 2(3):431-49. PubMed ID: 15151488 [TBL] [Abstract][Full Text] [Related]
55. [Statines for all or individualized lipid lowering therapy?]. Parhofer K MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849 [No Abstract] [Full Text] [Related]